Ticker: PCSA

Company: Processa Pharmaceuticals, Inc.

Person: David Young, director, officer

Transaction date: April 30, 2026

Reporting date: May 1, 2026

Average share price: 2.6900000000000004

Bought 1706.0 shares for 4589.14